Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;78(7):1032-1042.
doi: 10.1111/his.14324. Epub 2021 Apr 14.

Correlation of methylthioadenosine phosphorylase (MTAP) protein expression with MTAP and CDKN2A copy number in malignant pleural mesothelioma

David B Chapel  1 , Adrian M Dubuc  1 , Jason L Hornick  1 , Lynette M Sholl  1
Affiliations

Correlation of methylthioadenosine phosphorylase (MTAP) protein expression with MTAP and CDKN2A copy number in malignant pleural mesothelioma

David B Chapel et al. Histopathology. 2021 Jun.

Abstract

Aims: Methylthioadenosine phosphorylase (MTAP) immunohistochemical expression is a specific marker of CDKN2A deletion in malignant mesothelioma. However, the relationship of MTAP expression with MTAP copy number remains unexplored.

Methods and results: Forty malignant pleural mesotheliomas were characterised by targeted next-generation sequencing (29), single-nucleotide polymorphism microarray (seven), or both (four). MTAP and CDKN2A copy numbers were correlated with MTAP expression. Twenty-seven (68%) tumours showed CDKN2A deletion (14 heterozygous; 13 homozygous), of which 20 (74%) showed MTAP codeletion (15 heterozygous; five homozygous). No tumours showed MTAP deletion without CDKN2A codeletion. Loss of MTAP expression was seen in 16 (40%) tumours, and was 75% sensitive and 95% specific for MTAP deletion, and 59% sensitive and 100% specific for CDKN2A deletion. Nine of 40 (23%) tumours showed heterogeneous MTAP staining, and the percentage of tumour cells with MTAP loss correlated with molecular detection of MTAP deletion.

Conclusions: MTAP is frequently codeleted with CDKN2A in pleural mesothelioma. However, homozygous deletion of both genes occurs in a minority of tumours (5/40; 13%); CDKN2A deletion often co-occurs with heterozygous MTAP deletion or neutral MTAP copy number; and MTAP expression correlates inconsistently with heterozygous MTAP deletion. Correspondingly, MTAP immunohistochemistry is a highly specific but only moderately sensitive assay for CDKN2A deletion.

Keywords: cytogenetics; high-throughput nucleotide sequencing; immunohistochemistry; mesothelioma.

PubMed Disclaimer

References

    1. Neumann V, Löseke S, Nowak D et al. Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health. Dtsch. Arztebl. Int. 2013; 110; 319-326.
    1. Lehnert M, Kraywinkel K, Heinze E et al. Incidence of malignant mesothelioma in Germany 2009-2013. Cancer Causes Control 2017; 28; 97-105.
    1. Soeberg MJ, Leigh J, van Zandwijk N. Malignant mesothelioma in Australia 2015: current incidence and asbestos exposure trends. J. Toxicol. Environ. Health B Crit. Rev. 2016; 19; 173-189.
    1. Jane Henley S, Larson TC, Wu M et al. Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003-2008. Int. J. Occup. Environ. Health 2013; 19; 1-10.
    1. Price B, Ware A. Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005. Crit. Rev. Toxicol. 2009; 39; 576-588.

MeSH terms

Substances

LinkOut - more resources